POLYMED — Poly Medicure Balance Sheet
0.000.00%
- IN₹225.03bn
- IN₹214.68bn
- IN₹16.70bn
Annual balance sheet for Poly Medicure, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 3,743 | 3,517 | 3,013 | 2,923 | 12,158 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2,011 | 2,590 | 2,878 | 3,225 | 3,501 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,058 | 7,834 | 8,070 | 8,416 | 19,170 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,910 | 4,770 | 6,624 | 8,889 | 11,302 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 12,237 | 13,768 | 15,772 | 18,587 | 31,925 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,714 | 2,267 | 2,933 | 3,512 | 3,702 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,582 | 2,894 | 3,356 | 3,886 | 4,268 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 9,656 | 10,875 | 12,416 | 14,701 | 27,657 |
Total Liabilities & Shareholders' Equity | 12,237 | 13,768 | 15,772 | 18,587 | 31,925 |
Total Common Shares Outstanding |